COVID-19:  Corporate Update 03/23/2020 Donation of hydroxychloroquine to Canadian hospitals to combat COVID-19 JAMP Pharma Group announces that it is donating one million doses of hydroxychloroquine to Canadian hospitals, a drug that is normally used to treat malaria and rheumatoid arthritis and which could potentially be useful in treating hospitalized patients infected with the COVID-19

COVID-19:  Corporate Update 03/17/2020 Our action plan to manage the COVID-19 crisis: Based on our detailed evaluation combined with our strategic efforts to prepare for operational disruptions, we do not anticipate any short term inventory or supply issues. We will continue to monitor the situation very closely and remain in continuous communication with our customers